Sproxil is an American technology company that builds trust across supply chains with solutions that emphasize direct engagement.
We launched with a focus on counterfeit medicines
Counterfeit medicine is a dangerous, multi-billion dollar problem that plagues patients, regulatory bodies, and the global health care industry. Fake anti-malarial and tuberculosis drugs alone account for over 700,000 reported annual deaths, according to the International Policy Network.
The issue is worse in emerging markets, where limited oversight and smaller budgets create opportunities for counterfeiters to profit from the lives of others.